Cardinal Health, Inc. $CAH Shares Sold by Swiss Life Asset Management Ltd

Swiss Life Asset Management Ltd lessened its holdings in Cardinal Health, Inc. (NYSE:CAHFree Report) by 9.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 69,381 shares of the company’s stock after selling 7,355 shares during the period. Swiss Life Asset Management Ltd’s holdings in Cardinal Health were worth $14,258,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Strategy Asset Managers LLC purchased a new stake in Cardinal Health during the 3rd quarter worth about $775,000. Mirae Asset Global Investments Co. Ltd. raised its position in Cardinal Health by 15.3% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 37,833 shares of the company’s stock valued at $5,938,000 after purchasing an additional 5,030 shares in the last quarter. Versor Investments LP purchased a new position in shares of Cardinal Health in the 3rd quarter valued at about $2,090,000. Atle Fund Management AB grew its position in shares of Cardinal Health by 13.1% during the third quarter. Atle Fund Management AB now owns 30,297 shares of the company’s stock worth $4,755,000 after buying an additional 3,500 shares in the last quarter. Finally, Nordea Investment Management AB grew its position in shares of Cardinal Health by 328.3% during the fourth quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after buying an additional 494,731 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

CAH has been the topic of several analyst reports. Leerink Partners reaffirmed an “outperform” rating and issued a $275.00 target price on shares of Cardinal Health in a report on Monday, March 9th. TD Cowen boosted their price target on shares of Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a report on Friday, May 1st. William Blair began coverage on shares of Cardinal Health in a research report on Tuesday, April 28th. They issued an “outperform” rating on the stock. Mizuho raised their price objective on shares of Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a report on Friday, February 6th. Finally, Morgan Stanley lifted their price objective on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 28th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $241.80.

View Our Latest Stock Report on Cardinal Health

Cardinal Health Stock Down 0.6%

CAH stock opened at $182.63 on Tuesday. The business has a 50 day moving average price of $209.97 and a 200 day moving average price of $207.30. The stock has a market cap of $42.77 billion, a price-to-earnings ratio of 27.93, a PEG ratio of 1.09 and a beta of 0.53. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60.

Cardinal Health (NYSE:CAHGet Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same period in the prior year, the firm posted $2.35 earnings per share. The firm’s revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a $0.5158 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.1%. Cardinal Health’s payout ratio is 31.19%.

About Cardinal Health

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Recommended Stories

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.